Adjuvant Holdings Co., Ltd. (TSE: 4929) reported consolidated results for the first quarter of the fiscal year ending March 2027 (March 21 – June 20, 2026) under Japanese GAAP. Revenue rose 9.7% to ¥1,051 million and the salon-channel cosmetics group swung to an operating profit of ¥46 million from a ¥10 million operating loss a year earlier. Ordinary profit reached ¥51 million, reversing a ¥12 million ordinary loss, and net profit attributable to owners of the parent jumped 442.7% to ¥61 million. Quarterly earnings per share climbed to ¥7.66 from ¥1.41.
New product launches drive a broad-based top-line gain
Adjuvant sells through hair and beauty salons rather than mass retail, and the quarter's growth came from pushing priority products through that channel. The company staged its first salon invitation event in six years, which it credits with lifting motivation across its distributor and salon partners and improving the flow of recommendations from distributors to salons and from salons to end consumers. The number of actively trading salons reached 11,950, up 632 from a year earlier.
Skincare outpaces haircare on the rafuna makeup launch
Skincare — the smaller of the two product lines — was the standout, with revenue up 23.3% to ¥422 million and its share of the mix widening to 40.2% from 35.8%. The May 2026 launch of the "rafuna" makeup brand's cover foundation, supported by makeup-artist-led touch-up sessions in salons, lifted the rafuna line and pulled other brands along with it. Haircare rose 5.5% to ¥692 million, helped by the May 2026 launch of the "Re:>>> Platinum Plus Cream Shampoo" color-care product. Other revenue fell 73.0% to ¥6 million following a change in the consolidation scope, and sales rebates deducted ¥70 million. By geography, domestic revenue rose 11.4% to ¥1,009 million (96.0% of the total) while overseas revenue slipped 19.0% to ¥42 million. The group operates as a single reportable segment, so no segment breakdown is disclosed.
Cost discipline amplifies the operating swing
The profit reversal reflects both sides of the income statement. Gross profit rose to ¥713 million from ¥675 million on the higher sales base, while selling, general and administrative expenses fell to ¥667 million from ¥685 million on reduced advertising spend — a rare combination that flipped the operating line by roughly ¥57 million year on year. Dividend income and foreign-exchange gains added a further ¥5 million of non-operating income, and a ¥10 million tax benefit lifted the bottom line above the pre-tax figure. Comprehensive income rose 287.1% to ¥71 million. Depreciation was ¥20 million, down from ¥23 million.
Balance sheet, guidance and dividend
Total assets stood at ¥5,213 million at the quarter-end, up ¥64 million from the previous fiscal year-end, with accounts receivable up ¥121 million and inventories down ¥67 million. Net assets eased ¥25 million to ¥4,193 million as a ¥96 million dividend payment more than offset the quarter's ¥61 million profit, leaving the equity ratio at a conservative 80.4% (from 81.9%) and book value per share at ¥524.15. Adjuvant left its full-year forecast unchanged from the guidance issued on April 17, 2026: revenue of ¥4,052 million (+6.3%), operating profit of ¥50 million (−70.2%), ordinary profit of ¥52 million (−74.0%) and net profit of ¥24 million (−82.7%), or ¥3.09 per share. That leaves the first quarter having already delivered 92% of the full-year operating-profit target and more than double the full-year net-profit target — a gap the company has not yet moved to revise. The annual dividend forecast is unchanged at ¥12.00 per share, all payable at year-end, matching the prior year.
| Metric | Q1 FY3/2027 | Q1 FY3/2026 | YoY |
|---|---|---|---|
| Revenue (¥ million) | 1,051 | 958 | +9.7% |
| Operating profit (loss) (¥ million) | 46 | −10 | n.m. |
| Ordinary profit (loss) (¥ million) | 51 | −12 | n.m. |
| Net profit (¥ million) | 61 | 11 | +442.7% |
| EPS (¥) | 7.66 | 1.41 | +443.3% |
| Skincare revenue (¥ million) | 422 | 342 | +23.3% |
| Haircare revenue (¥ million) | 692 | 656 | +5.5% |
| Total assets (¥ million) | 5,213 | 5,148* | +1.3% |
| Equity ratio (%) | 80.4 | 81.9* | −1.5pt |
* Balance-sheet comparatives are as of the previous fiscal year-end (March 20, 2026), not the year-earlier quarter.
JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.